Establishment Labs Holdings (ESTA) Net Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -411.74% |
| Dec 31, 2025 | 76.54% |
| Sep 30, 2025 | 32.83% |
| Jun 30, 2025 | 19.88% |
| Mar 31, 2025 | 40.02% |
| Dec 31, 2024 | -107.00% |
| Sep 30, 2024 | 2.90% |
| Jun 30, 2024 | -6.04% |
| Mar 31, 2024 | 21.13% |
| Dec 31, 2023 | 29.83% |
| Sep 30, 2023 | -74.82% |
| Jun 30, 2023 | -40.22% |
| Mar 31, 2023 | 11.95% |
| Dec 31, 2022 | 27.12% |
| Sep 30, 2022 | 49.85% |
| Jun 30, 2022 | -525.42% |
| Mar 31, 2022 | 58.19% |
| Dec 31, 2021 | 3.32% |
| Sep 30, 2021 | -175.80% |
| Jun 30, 2021 | 23.40% |
| Mar 31, 2021 | -22.95% |
| Dec 31, 2020 | -33.12% |
| Sep 30, 2020 | 59.46% |
| Jun 30, 2020 | 41.01% |
| Mar 31, 2020 | -219.53% |
| Dec 31, 2019 | 56.51% |
| Sep 30, 2019 | -41.32% |
| Jun 30, 2019 | 16.13% |
| Mar 31, 2019 | -2.52% |
| Dec 31, 2018 | -905.05% |
| Sep 30, 2018 | 124.37% |
| Jun 30, 2018 | 17.92% |
| Mar 31, 2018 | 8.45% |
| Dec 31, 2017 | 33.17% |
| Sep 30, 2017 | 11.72% |